Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 7 | 54 | 14 | 0 | 0 |
| Gross Profit | 7 | 54 | 14 | N/A | -9 |
| Operating Expenses | 4,557 | 4,395 | 5,624 | 4,580 | 4,737 |
| Operating Income | -4,550 | -4,341 | -5,610 | -4,580 | -4,737 |
| Interest Expense | 0 | 7 | 9 | 9 | 10 |
| Other Income | -111 | -49 | 208 | -504 | -320 |
| Pre-tax Income | -4,661 | -4,397 | -5,411 | -5,093 | -5,067 |
| Net Income Continuous | -4,661 | -4,397 | -5,411 | -5,093 | -5,067 |
| Net Income | $-4,661 | $-4,397 | $-5,411 | $-5,093 | $-5,067 |
| EPS Basic Total Ops | -0.13 | -2.67 | -3.34 | -7.98 | 2,087.80 |
| EPS Basic Continuous Ops | -0.13 | -2.67 | -3.34 | -7.97 | 2,078.89 |
| EPS Diluted Total Ops | -0.13 | -2.67 | -3.34 | -7.98 | 2,087.80 |
| EPS Diluted Continuous Ops | -0.13 | -2.67 | -3.34 | -7.97 | 2,078.89 |
| EBITDA(a) | $-4,529 | $-4,309 | $-5,569 | $-4,538 | $-4,731 |